VRCA Live-Signale | Maximieren Sie Profite mit Getagraph.com

KAUFEN 109645 min ago

@ $5.55

Ausgestellt: 13 Feb 2024 @ 16:00

Rendite: 28.04%

Vorheriges Signal: Feb 9 - 17:12

Vorheriges Signal: Verkaufen

Rendite: 2.31 %

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 20:24):

Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States...

Stats
Tagesvolumen	238 726
Durchschnittsvolumen	137 296
Marktkapitalisierung	301.18M
EPS	$0 ( 2024-02-29 )
Nächstes Ertragsdatum	( $-0.530 ) 2024-05-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-4.80
ATR14	$0.0230 (0.32%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-15	Hayes Christopher G.	Buy	40 000	Common Stock
2024-03-15	Hayes Christopher G.	Buy	80 000	Employee Stock Option (right to buy)
2024-03-15	Goldenberg Gary	Buy	40 000	Common Stock
2024-03-15	Goldenberg Gary	Buy	80 000	Employee Stock Option (right to buy)
2024-03-15	Kohler Terry	Buy	80 000	Employee Stock Option (right to buy)

INSIDER POWER
90.98
Last 98 transactions
Buy: 14 420 498 \| Sell: 288 608

Volumen Korrelation

Lang: 0.05 (neutral)

Kurz: 0.86 (strong)

Signal:(49.28) Same movement expected

Verrica Pharmaceuticals Korrelation

10 Am meisten positiv korreliert
TGTX	0.959
IDCC	0.956
SLMBP	0.955
VBOCU	0.955
RAM	0.95
WKEY	0.95
OVLY	0.948
NCAC	0.947
MESA	0.946
GPACU	0.945

10 Am meisten negativ korreliert
CBNK	-0.945
CYTO	-0.939
GSMG	-0.938
GNTY	-0.936
BFRI	-0.936
FGBI	-0.936
GOOD	-0.934
AMNB	-0.93
CMLS	-0.929
ALHC	-0.927

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Verrica Pharmaceuticals Korrelation - Währung/Rohstoff

0.50
( neutral )

-0.22
( neutral )

0.00
( neutral )

-0.28
( neutral )

-0.50
( neutral )

-0.03
( neutral )

Verrica Pharmaceuticals Finanzdaten

Annual	2023
Umsatz:	$5.12M
Bruttogewinn:	$3.96M (77.28 %)
EPS:	$-1.480

FY	2023
Umsatz:	$5.12M
Bruttogewinn:	$3.96M (77.28 %)
EPS:	$-1.480

FY	2022
Umsatz:	$9.03M
Bruttogewinn:	$8.31M (91.97 %)
EPS:	$-0.810

FY	2021
Umsatz:	$12.00M
Bruttogewinn:	$12.00M (100.00 %)
EPS:	$-1.300

Financial Reports:

No articles found.

Verrica Pharmaceuticals

Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and which is in Phase II clinical trial for treating common warts. It is also developing cantharidin-based product candidate, VP-103 for treating plantar warts. The company has a license and collaboration agreement with Torii Pharmaceutical Co., Ltd. for the development and commercialization of its product candidates for the treatment of molluscum contagiosum and common warts in Japan, including VP-102; and a license agreement with Lytix Biopharma AS to develop and commercialize LTX-315 for dermatological oncology indications. Verrica Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in West Chester, Pennsylvania.